API australian pharmaceutical industries limited

2012 half year result, page-5

  1. 2,515 Posts.
    lightbulb Created with Sketch. 214
    Solid half year result on which to build.

    Last 10 years have been pretty tough and disappointing and were the result of a combination some pretty poor leadership, poor financial management and some things beyond their control.

    I think we now have a pretty solid base on which to build and take advantage the opportunities flowing from the ageing population.

    Definitely a long term buy to put away and collect some solid dividends in the future.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.